VACCELERATE Volunteer Registry is a database where one can register if they are interested in participating in a clinical trial. These are primarily studies connected to COVID-19 vaccine and other infectious disease vaccines such as monkey pox. VACCELERATE has now issued a new brochure explaining the Volunteer Registry and how you can join it. Download…
Read more
Nina Urke Ertesvåg, PhD student at the Influenza Centre, presented results of her research on the recognition of different influenza viruses by the immune system in NRK. The findings showed that people who have received several vaccines more often recognize viruses from several strains. – We have proven that the influenza vaccine works more broadly…
Read more
The manuscript on ‘Vaccination rates in Europe are not associated with online media intensity’, written by VACCELERATE consortium has been published open access in the Journal of Science Communication. One of the co-authors of the manuscript is Professor Rebecca Cox, Head of the Influenza Centre. You can find the full publication here: https://doi.org/10.22323/2.21050205, and read…
Read more
In an interview for the Norwegian TV2, Nina Langeland and Rebecca Cox explained the results of a new study conducted by the University of Bergen and Haukeland University Hospital on long COVID. – As many as 46 percent of the COVID patients in our study report long-term effects, and that is high, said Nina Langeland,…
Read more
We have published a case report about an immunocompromised patient (treated with Rituximab against multiple sclerosis) with longterm fever, hypoxia and low-grade SARS-CoV-2 infection. The patient was hospitalized three times over a period of 102 days. The case report describes the clinical and diagnostic challenges and the interdisciplinary team work needed to distinguish hyperinflammation from…
Read more
Although most people who undergo SARS-CoV-2 infection recover, a significant proportion suffer long-term symptoms and late sequelae, also known as long COVID. We investigated long COVID symptoms in 233 people with a mild to moderate course of acute COVID-19. Our study showed that 46% of COVID-19 infected participants had one or more long COVID symptoms…
Read more
An educational video for kids from the VACCELERATE project about the importance and value of clinical trials is now available in several languages (English, German, Greek and Spanish). Listen to what the fairy “Well-being” has to say: https://youtube.com/watch?v=YZqPSe-YyxY
The VACCELERATE clinical research network that the Influenza Centre is engaged in has issued its first newsletter. You can access the full version on the VACCELERATE website: https://vaccelerate.eu/newsletters/ Check it out!
Our colleague Sarah Larteley Lartey Jalloh successfully defended her PhD thesis entitled “Humoral and cellular immune responses after pandemic and seasonal influenza vaccination in humans” on June 22, 2022. Her work was supervised by the Head of the Influenza Centre – Professor Rebecca Cox, and co-supervisors – Åsne Jul-Larsen and Fan Zhou. Sarah’s trial lecture…
Read more
50 people from Bergen who are 75 years old or older will receive the fourth dose of the mRNA vaccine against COVID-19, as part of the EU-COVAT AGED study connected to the VACCELERATE project aiming to investigate how the immune system responds to one more booster dose of the vaccine. 20 patients have already been…
Read more
English